Journal ArticleOPEN ACCESS

Effects of concomitant combination of SGLT-2 inhibitor and GLP-1 receptor agonist on renal outcomes in T2D with eGFR below 30 and macroalbuminuria: A case series

Clinical Case Reports (2021) 9(4) 2310-2316
DOI: 10.1002/ccr3.4022
5Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Renal protection is likely to be a class effect of SGLT-2 inhibitors and GLP-1RA. When used simultaneously, there may be a synergistic effect. Both agents are also safe to use in high renal risk patients (eGFR between 21 and 30 mL/min/1.73m2).

Author supplied keywords

Cite

CITATION STYLE

APA

Kuhadiya, N. D., & Mahmood, I. (2021). Effects of concomitant combination of SGLT-2 inhibitor and GLP-1 receptor agonist on renal outcomes in T2D with eGFR below 30 and macroalbuminuria: A case series. Clinical Case Reports, 9(4), 2310–2316. https://doi.org/10.1002/ccr3.4022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free